Matches in SemOpenAlex for { <https://semopenalex.org/work/W1523874686> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W1523874686 abstract "Lung cancer is the leading cause of cancer-related mortality worldwide. Although a platinum-doublet regimen has become the standard of care, the benefit is modest and the 5-year survival rate has remained essentially unchanged over the past 3 decades. Recently, several molecular alterations have been defined as “driver mutations,“ such as mutations in epidermal growth factor receptor (EGFR), KRas, chimeric tyrosine kinases involving ALK, RET, ROS1. And molecular targeting therapies for lung adenocarcinoma, targeting mutant EGFR or ALK, RET and ROS1 fusions, limit non-tumor toxicity and extend survival time compared to the conventional chemotherapies. However, there is no effective molecularly targeted therapy for mutant KRas-driven lung adenocarcinoma, the most frequent type of lung adenocarcinoma in the Caucasian population. Therefore, specific therapies that target various lung tumor types are desperately needed. Midkine (MDK) is a heparin-binding growth factor that is highly expressed in many malignant tumors, including lung cancers. We have previously reported that a MDK inhibitor: iMDK suppresses non-small cell lung cancer expressing MDK in vitro and in vivo without harming normal cells. Importantly, iMDK inhibits the PI3 kinase / Akt pathway and induces apoptosis in MDK expressing non-small cell lung cancer cells. In the present study, we have investigated the combination effect of iMDK and a mitogen-activated protein/extracellular signal-regulated kinase (MEK) inhibitor PD0325901. The combination treatment of iMDK and PD0325901 more effectively suppressed cell viability and colony formation, increased caspase-3 activity and induced apoptosis than those of single use in H441 and H2009 pulmonary adenocarcinoma cells harboring a G12 KRas mutation. Here, we describe the efficacy of the use of iMDK and PD0325901 for patients with inoperable advanced lung cancer including pulmonary adenocarcinoma harboring KRas mutations. Citation Format: Takuya Fukazawa, Yutaka Maeda, Naomasa Ishida, Tomoki Yamatsuji, Munenori Takaoka, Minoru Haisa, Nagio Takigawa, Jeffery Whitsett, Yoshio Naomoto. Effective use of MDK/Midkine and MEK inhibitor to treat KRas mutated pulmonary adenocarcinoma cells. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 744. doi:10.1158/1538-7445.AM2014-744" @default.
- W1523874686 created "2016-06-24" @default.
- W1523874686 creator A5001897650 @default.
- W1523874686 creator A5020414608 @default.
- W1523874686 creator A5021348937 @default.
- W1523874686 creator A5029945319 @default.
- W1523874686 creator A5034692531 @default.
- W1523874686 creator A5050020629 @default.
- W1523874686 creator A5082617727 @default.
- W1523874686 creator A5086029895 @default.
- W1523874686 creator A5087798766 @default.
- W1523874686 date "2014-09-30" @default.
- W1523874686 modified "2023-09-26" @default.
- W1523874686 title "Abstract 744: Effective use of MDK/Midkine and MEK inhibitor to treat KRas mutated pulmonary adenocarcinoma cells" @default.
- W1523874686 doi "https://doi.org/10.1158/1538-7445.am2014-744" @default.
- W1523874686 hasPublicationYear "2014" @default.
- W1523874686 type Work @default.
- W1523874686 sameAs 1523874686 @default.
- W1523874686 citedByCount "0" @default.
- W1523874686 crossrefType "proceedings-article" @default.
- W1523874686 hasAuthorship W1523874686A5001897650 @default.
- W1523874686 hasAuthorship W1523874686A5020414608 @default.
- W1523874686 hasAuthorship W1523874686A5021348937 @default.
- W1523874686 hasAuthorship W1523874686A5029945319 @default.
- W1523874686 hasAuthorship W1523874686A5034692531 @default.
- W1523874686 hasAuthorship W1523874686A5050020629 @default.
- W1523874686 hasAuthorship W1523874686A5082617727 @default.
- W1523874686 hasAuthorship W1523874686A5086029895 @default.
- W1523874686 hasAuthorship W1523874686A5087798766 @default.
- W1523874686 hasConcept C121608353 @default.
- W1523874686 hasConcept C126322002 @default.
- W1523874686 hasConcept C158074577 @default.
- W1523874686 hasConcept C170493617 @default.
- W1523874686 hasConcept C184235292 @default.
- W1523874686 hasConcept C2775960820 @default.
- W1523874686 hasConcept C2775999482 @default.
- W1523874686 hasConcept C2776256026 @default.
- W1523874686 hasConcept C2779438470 @default.
- W1523874686 hasConcept C2781182431 @default.
- W1523874686 hasConcept C2781187634 @default.
- W1523874686 hasConcept C2781249067 @default.
- W1523874686 hasConcept C2908647359 @default.
- W1523874686 hasConcept C502942594 @default.
- W1523874686 hasConcept C526805850 @default.
- W1523874686 hasConcept C57074206 @default.
- W1523874686 hasConcept C71924100 @default.
- W1523874686 hasConcept C86803240 @default.
- W1523874686 hasConcept C95444343 @default.
- W1523874686 hasConcept C99454951 @default.
- W1523874686 hasConceptScore W1523874686C121608353 @default.
- W1523874686 hasConceptScore W1523874686C126322002 @default.
- W1523874686 hasConceptScore W1523874686C158074577 @default.
- W1523874686 hasConceptScore W1523874686C170493617 @default.
- W1523874686 hasConceptScore W1523874686C184235292 @default.
- W1523874686 hasConceptScore W1523874686C2775960820 @default.
- W1523874686 hasConceptScore W1523874686C2775999482 @default.
- W1523874686 hasConceptScore W1523874686C2776256026 @default.
- W1523874686 hasConceptScore W1523874686C2779438470 @default.
- W1523874686 hasConceptScore W1523874686C2781182431 @default.
- W1523874686 hasConceptScore W1523874686C2781187634 @default.
- W1523874686 hasConceptScore W1523874686C2781249067 @default.
- W1523874686 hasConceptScore W1523874686C2908647359 @default.
- W1523874686 hasConceptScore W1523874686C502942594 @default.
- W1523874686 hasConceptScore W1523874686C526805850 @default.
- W1523874686 hasConceptScore W1523874686C57074206 @default.
- W1523874686 hasConceptScore W1523874686C71924100 @default.
- W1523874686 hasConceptScore W1523874686C86803240 @default.
- W1523874686 hasConceptScore W1523874686C95444343 @default.
- W1523874686 hasConceptScore W1523874686C99454951 @default.
- W1523874686 hasLocation W15238746861 @default.
- W1523874686 hasOpenAccess W1523874686 @default.
- W1523874686 hasPrimaryLocation W15238746861 @default.
- W1523874686 hasRelatedWork W1565370786 @default.
- W1523874686 hasRelatedWork W2002144745 @default.
- W1523874686 hasRelatedWork W2019943563 @default.
- W1523874686 hasRelatedWork W2185181061 @default.
- W1523874686 hasRelatedWork W2330501746 @default.
- W1523874686 hasRelatedWork W2331073685 @default.
- W1523874686 hasRelatedWork W2382521520 @default.
- W1523874686 hasRelatedWork W2503568177 @default.
- W1523874686 hasRelatedWork W2522698104 @default.
- W1523874686 hasRelatedWork W2550825547 @default.
- W1523874686 hasRelatedWork W2564580923 @default.
- W1523874686 hasRelatedWork W2597070303 @default.
- W1523874686 hasRelatedWork W2886185950 @default.
- W1523874686 hasRelatedWork W2886542533 @default.
- W1523874686 hasRelatedWork W2887201603 @default.
- W1523874686 hasRelatedWork W2889974946 @default.
- W1523874686 hasRelatedWork W2900191283 @default.
- W1523874686 hasRelatedWork W2902674912 @default.
- W1523874686 hasRelatedWork W2905197484 @default.
- W1523874686 hasRelatedWork W2947028469 @default.
- W1523874686 isParatext "false" @default.
- W1523874686 isRetracted "false" @default.
- W1523874686 magId "1523874686" @default.
- W1523874686 workType "article" @default.